Molecular residual disease (MRD) testing detects cancer recurrence months before traditional imaging Labcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA ...
Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer the only blood test cleared by the U.S. Food and Drug Administration to aid ...
April 30 (Reuters) - Labcorp raised its full-year profit and revenue forecast on Thursday after posting quarterly results ...
By Sahil Pandey April 30 (Reuters) - Labcorp raised its full-year profit and revenue forecast on Thursday after posting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results